Leigh Turner

Perspectives: Nature editorial on stem cell oversight & clinics gets it right

Turner-Knoepfler-Figure-2

The journal Nature published an excellent editorial earlier this week on stem cell oversight and stem cell clinics. The piece, entitled ” FDA should stand firm on stem-cell treatments. US regulators must regain the upper hand in the approval system” struck just the right balance. It correctly supported the FDA’s data-centered approach to stem cell oversight and …

Perspectives: Nature editorial on stem cell oversight & clinics gets it right Read More »

New paper shows huge American stem cell clinic industry: 570 locations

Figure-1-Turner-Knoepfler-Stem-Cell-Clinics-e1467311048838

My colleague Leigh Turner and I today published a new paper in Cell Stem Cell documenting for the first time the American stem cell clinic arena in a comprehensive way, which we found as of February has a remarkable 570 clinic locations via 351 businesses. These numbers are way beyond the predictions of most researchers …

New paper shows huge American stem cell clinic industry: 570 locations Read More »

Huge clinical trial patient fees allowed by FDA at times, details often secret

Monopoly1-300x2851

I am often critical of for-profit stem cell clinics on this blog for numerous reasons. For instance, one thing that concerns me greatly about these clinics is that they charge patients to get experimental “treatments” that have not been proven to be safe or effective. But as some patients have pointed out to me over the …

Huge clinical trial patient fees allowed by FDA at times, details often secret Read More »

Do for-profit stem cell studies have inherent potential biases?

There’s been an interesting and diverse discussion going on here on this blog lately related to some stem cell translational things including a stem cell clinic operating in Sacramento (see 50+ comments on that post) and then more recently on a new paper from the Centeno clinic. [email protected] Did most (or all) participants in this study pay …

Do for-profit stem cell studies have inherent potential biases? Read More »

Predatory stem cell clinics are winning: what can we do?

Stem-cell-facelift-comic-e1452454386279

For years I have been working to educate the community about the predatory stem cell clinics out there. These clinics prey on vulnerable patients and their families. The clinics use hope as a marketing tool. A weapon. As the number of such clinics has mushroomed in the US and elsewhere the risk to both patients …

Predatory stem cell clinics are winning: what can we do? Read More »

Dilemmas When Patients Ponder Cowboy Stem Cell Clinics

Stem-cell-facelift-comic-e1452454386279

What should the stem cell field try to do about cowboy stem cell clinics? By this term I mean those that don’t follow the rules. They shoot stem cells into customers first and ask questions later. I’ve interacted with many patients over the years who are interested in stem cells. This interaction is growing much …

Dilemmas When Patients Ponder Cowboy Stem Cell Clinics Read More »

Meeting review of unique stem cell ethics symposium @UCDAVIS

Stem-cell-ethics-meeting-e1479769073498

On Thursday here at UC Davis School of Medicine we held our second annual Stem Cell Ethics Symposium. The symposium was organized by Drs. Mark Yarborough and Nanette Joyce as well as me. In this post I report on key take homes from the meeting and summarize the specific talks. As far as I know, this is one of the few …

Meeting review of unique stem cell ethics symposium @UCDAVIS Read More »

UC Davis 2nd Annual Stem Cell Ethics Symposium: Save the Date Feb. 12

stem-cell-ethics

We here at UC Davis School of Medicine are gearing up for our 2nd annual Stem Cell Ethics Symposium (see flyer). As one of the organizers, I’m really excited about our lineup of speakers including Timothy Caulfield, Leigh Turner, Alison Sorkin, Mary Ann Chirba, and Richard Garr as well as others. We will be focusing …

UC Davis 2nd Annual Stem Cell Ethics Symposium: Save the Date Feb. 12 Read More »